Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.
about
Single agent versus combination chemotherapy for metastatic breast cancerFirst-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study.A Review of Systemic Treatment in Metastatic Triple-Negative Breast CancerCurrent approaches in treatment of triple-negative breast cancerMeta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancerSystemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelinesSystems modeling of anti-apoptotic pathways in prostate cancer: psychological stress triggers a synergism pattern switch in drug combination therapyGerman Adjuvant Intergroup Node-positive Study (GAIN): A Phase III Trial Comparing Two Dose-Dense Regimens (iddEPC vs. ddEC-PwX) in High-Risk Early Breast Cancer Patients.A meta-analysis of combination therapy versus single-agent therapy in anthracycline- and taxane-pretreated metastatic breast cancer: results from nine randomized Phase III trials.Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel.Phase I-II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancerCapecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trialCapecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial.A dose escalation study of docetaxel plus capecitabine in combination with oxaliplatin in patients with advanced solid tumors.Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.Docetaxel plus oxaliplatin in combination with capecitabine as first-line treatment for advanced gastric cancer.Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma.A phase 1, dose-finding and pharmacokinetic study of gemcitabine with nab-paclitaxel in patients with metastatic breast cancer.Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review studySurvival data of patients with anthracycline- or taxane-pretreated or resistant metastatic breast cancer.A pooled analysis of gemcitabine plus docetaxel versus capecitabine plus docetaxel in metastatic breast cancerNorth Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancerCapecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane.S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancerRecurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life.Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer.Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trialEffect of a structured, active, home-based cancer-treatment program for the management of patients on oral chemotherapyAge-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden.Depression and anxiety in women with early breast cancer: five year observational cohort study.Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma.Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel mSynergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell lines.Experience in Phase I Trials and an Upcoming Phase II Study with uPA Inhibitors in Metastatic Breast Cancer.The Role of Combination Chemotherapy in the Treatment of Patients with Metastatic Breast Cancer.Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors.First efficacy results of capecitabine with anthracycline- and taxane-based adjuvant therapy in high-risk early breast cancer: a meta-analysisOptimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer.Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
P2860
Q24241459-F5D68D8D-532E-405D-BE66-7869B389A46FQ24812405-5F22B0E3-4178-4DAF-902B-61CA1D81DADDQ26752846-62D5CA94-A170-410C-BB70-F557888A6D38Q26801549-1099FFE7-D2C2-4EFA-B610-EF07BBDFBEC7Q26860469-5FEB615D-C6A7-4251-8CC8-84A5BF7C3013Q28080469-FC441B34-76B4-4044-8D13-4310F5CD43E2Q28536000-4E422753-4B09-4E13-AD19-9579A9A08BBDQ30313214-B1639ED6-F439-4B2D-92B3-8435C2A37709Q30390845-E632EF90-56F1-4F42-ABF9-9331908D53DAQ33291247-7D082B17-C055-4952-85C4-C21BCC8E5246Q33347519-343C21D6-CAAA-4732-9265-EF2F726F652DQ33361603-D16F8402-C39D-42A6-96AC-0C91BEDC5C9BQ33377361-A8AA92B0-BC93-459E-B411-894501FAFBB6Q33386694-916F35BE-1ECF-44E0-91D6-275F9D3E5B14Q33391344-64421ECB-8791-4574-8896-CBD62408D5B9Q33396506-379F19DE-2AB8-4A08-9D4A-CF9C2274FD39Q33410891-64E6766D-6B49-4B36-8B7C-ED6936131675Q33433212-0B2D8157-549E-427A-9F0D-0877EE1DD448Q33506194-67267D8D-0D46-4A18-A34A-199294F56F64Q33516882-EDB0F397-20CE-49B6-81D2-8CF9705C704BQ33577876-9284FA73-6D3A-4673-837B-8AF8DF568F66Q33618149-5AEDD1EB-9FED-4003-860F-F07499E31FE0Q33631745-BE8EB4DD-B928-4962-A204-92006FFA1F92Q33643492-502B6E8E-8E04-4869-B8F6-1A05431B3F6FQ33659628-57E5197F-B07F-4731-8B91-5001C70B9A16Q33703527-5187D5DB-BD6B-445E-9BBF-1413C77AF5C9Q33765404-6192E325-2411-4B1A-9844-2C136CFD4C8DQ33821528-57BDFF61-C9B5-478A-B12E-B0C16FA424E6Q33831232-8E7BAD82-D6A1-49C6-8EF9-050BC986631EQ33913545-C363731C-4C93-4334-9B39-AEE296C38731Q33934898-802974CB-9774-4012-A55A-6EC86FA2524AQ34010159-6F303E45-EA7F-4FD0-99F2-A2E375E19399Q34020507-C5B686CF-85C7-46D1-81DD-D2C0651005A2Q34062522-FEC6E0C5-D257-4E24-911A-E54AF2DCC4FFQ34095789-3126B340-0023-4DCB-98B2-C1B1EF275A17Q34140051-B245D234-4707-4500-9D40-5F17925E04F3Q34183139-44917A28-7FAE-42C4-B6CE-198B6E726807Q34187204-04CB3AFE-FB08-4C7F-8DB8-6136C8470684Q34204598-37F791D1-D537-4674-BCA0-3D1A0FEE3DF8Q34271252-31CE5978-12CA-463D-B734-AA5A17CEBEE5
P2860
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Superior survival with capecit ...... ncer: phase III trial results.
@ast
Superior survival with capecit ...... ncer: phase III trial results.
@en
Superior survival with capecit ...... ncer: phase III trial results.
@en-gb
Superior survival with capecit ...... ncer: phase III trial results.
@nl
type
label
Superior survival with capecit ...... ncer: phase III trial results.
@ast
Superior survival with capecit ...... ncer: phase III trial results.
@en
Superior survival with capecit ...... ncer: phase III trial results.
@en-gb
Superior survival with capecit ...... ncer: phase III trial results.
@nl
prefLabel
Superior survival with capecit ...... ncer: phase III trial results.
@ast
Superior survival with capecit ...... ncer: phase III trial results.
@en
Superior survival with capecit ...... ncer: phase III trial results.
@en-gb
Superior survival with capecit ...... ncer: phase III trial results.
@nl
P2093
P356
P1476
Superior survival with capecit ...... ncer: phase III trial results.
@en
P2093
Chris Twelves
David Miles
Guadalupe Cervantes
Guy Van Hazel
Jean-Pierre Ayoub
Joyce O'Shaughnessy
Louis Mauriac
Pierre Fumoleau
Robert Leonard
Shailendra Verma
P304
P356
10.1200/JCO.2002.09.002
P407
P577
2002-06-01T00:00:00Z